Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Guiju Cai, Xiangyan Ruan, Muqing Gu, Yue Zhao, Yuejiao Wang & Alfred O. Mueck. (2020) PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study. Gynecological Endocrinology 36:11, pages 1024-1027.
Read now
Read now
Ying Su, Qing-Quan Lian & Ren-Shan Ge. (2012) Contraceptives with novel benefits. Expert Opinion on Investigational Drugs 21:1, pages 83-90.
Read now
Read now
Articles from other publishers (23)
C. Ángel-Parra, A.M. Pascual-Domenech & E. González-Mirasol. (2021) Riesgo de cáncer de mama en portadoras de DIU de levonorgestrel. Revisión sistemática. Clínica e Investigación en Ginecología y Obstetricia 48:4, pages 100668.
Crossref
Crossref
Norah A. Burchardt, Amy L. Shafrir, Rudolf Kaaks, Shelley S. Tworoger & Renée T. Fortner. (2020) Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947–1964: The Nurses’ Health Study II, a prospective cohort study. European Journal of Epidemiology 36:8, pages 827-839.
Crossref
Crossref
Domenique Ciriello & Nicole Cieri-Hutcherson. (2020) Pharmacists and Contraception in the Inpatient Setting. Pharmacy 8:2, pages 82.
Crossref
Crossref
Bao-Cheng Xie, Shu-Yong Song, Xiao-Yang Xie, Yu-Tong Sun, Xiao-Yuan Zhang, Dao-Hua Xu & Yun-Sheng Huang. (2019) Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate. Archiv der Pharmazie 352:3, pages 1800295.
Crossref
Crossref
. (2018) Contemporary Hormonal Contraception and the Risk of Breast Cancer. New England Journal of Medicine 378:13, pages 1263-1266.
Crossref
Crossref
Rogério Bonassi Machado. (2018) Hormonal Contraceptives and Risk of Breast Cancer: How to Explain it without Controversy. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 40:02, pages 057-058.
Crossref
Crossref
Lina S. Mørch, Charlotte W. Skovlund, Philip C. Hannaford, Lisa Iversen, Shona Fielding & Øjvind Lidegaard. (2017) Contemporary Hormonal Contraception and the Risk of Breast Cancer. New England Journal of Medicine 377:23, pages 2228-2239.
Crossref
Crossref
Marsha Samson, Nancy Porter, Olubunmi Orekoya, James R. Hebert, Swann Arp Adams, Charles L. Bennett & Susan E. Steck. (2015) Progestin and breast cancer risk: a systematic review. Breast Cancer Research and Treatment 155:1, pages 3-12.
Crossref
Crossref
Patrizia Ferraboschi, Pierangela Ciuffreda, Samuele Ciceri, Paride Grisenti, Carlo Castellano & Fiorella Meneghetti. (2015) Crystallographic and spectroscopic study on a known orally active progestin. Steroids 104, pages 137-144.
Crossref
Crossref
Min Wei, Qi He, Zhongyin Yang, Zhiwei Wang, Qing Zhang, Bingya Liu, Qinlong Gu, Liping Su, Yingyan Yu, Zhenggang Zhu & Guofeng Zhang. (2014) Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone. BMC Cancer 14:1.
Crossref
Crossref
Carlos Kubli-Garfias, Oscar González-Flores, Porfirio Gómora-Arrati, Gabriela González-Mariscal, Ricardo Vázquez-Ramírez & Carlos Beyer. (2013) Bimodal binding and free energy of the progesterone receptor in the induction of female sexual receptivity by progesterone and synthetic progestins. The Journal of Steroid Biochemistry and Molecular Biology 133, pages 43-50.
Crossref
Crossref
Luigi Strizzi, Katharine M Hardy, Naira V Margaryan, David W Hillman, Elisabeth A Seftor, Beiyun Chen, Xochiquetzal J Geiger, E Aubrey Thompson, Wilma L Lingle, Cathy A Andorfer, Edith A Perez & Mary JC Hendrix. (2012) Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Research 14:3.
Crossref
Crossref
Christina Justenhoven, Ofure Obazee, Stefan Winter, Fergus J. Couch, Janet E. Olson, Per Hall, Ulf Hannelius, Jingmei Li, Keith Humphreys, Gianluca Severi, Graham Giles, Melissa Southey, Laura Baglietto, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Ute Hamann, Christian Baisch, Volker Harth, Sylvia Rabstein, Anne Lotz, Beate Pesch, Thomas Brüning, Yon-Dschun Ko & Hiltrud Brauch. (2011) The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. Breast Cancer Research and Treatment 131:1, pages 347-350.
Crossref
Crossref
D. Cibula, A. Gompel, A. O. Mueck, C. La Vecchia, P. C. Hannaford, S. O. Skouby, M. Zikan & L. Dusek. (2010) Hormonal contraception and risk of cancer. Human Reproduction Update 16:6, pages 631-650.
Crossref
Crossref
Regine Sitruk-Ware & Anita Nath. (2010) The use of newer progestins for contraception. Contraception 82:5, pages 410-417.
Crossref
Crossref
Stefano Lello. (2010) Nomegestrol Acetate. Drugs 70:5, pages 541-559.
Crossref
Crossref
Jorge R. Pasqualini. (2009) Breast cancer and steroid metabolizing enzymes: The role of progestogens. Maturitas 65, pages S17-S21.
Crossref
Crossref
JoAnn V PinkertonDale W StovallRebecca S Kightlinger. (2009) Advances in the Treatment of Menopausal Symptoms. Women's Health 5:4, pages 361-384.
Crossref
Crossref
Giulia Guerriero. (2009) Vertebrate Sex Steroid Receptors: Evolution, Ligands, and Neurodistribution. Annals of the New York Academy of Sciences 1163:1, pages 154-168.
Crossref
Crossref
Carlo Campagnoli, Simona Ambroggio, Maria Rosa Lotano & Clementina Peris. (2009) Progestogen use in women approaching the menopause and breast cancer risk. Maturitas 62:4, pages 338-342.
Crossref
Crossref
Tess V. Clendenen, Karen L. Koenig, Roy E. Shore, Mortimer Levitz, Alan A. Arslan & Anne Zeleniuch-Jacquotte. (2009) Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 18:1, pages 275-281.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Lipidology 19:6, pages 600-614.
Crossref
Crossref
Martin Svoboda, Franz Sellner, Cem Ekmekcioglu, Martin Klimpfinger, Walter Jaeger & Theresia Thalhammer. (2008) Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder. Biomedicine & Pharmacotherapy 62:10, pages 690-696.
Crossref
Crossref